IGNACIO
RODRÍGUEZ RAMÍREZ DE ARELLANO
Profesor contratado doctor
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, EspañaPublications en collaboration avec des chercheurs de Centro Nacional de Investigaciones Cardiovasculares Carlos III (6)
2023
-
Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (Frontiers in Pharmacology, (2023), 14, (1021535), 10.3389/fphar.2023.1021535)
Frontiers in Pharmacology
-
Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
Frontiers in Pharmacology, Vol. 14
2021
-
HAP-Multitag, a PET and Positive MRI Contrast Nanotracer for the Longitudinal Characterization of Vascular Calcifications in Atherosclerosis
ACS Applied Materials and Interfaces, Vol. 13, Núm. 38, pp. 45279-45290
2019
-
Long-Term Dabigatran Treatment Delays Alzheimer's Disease Pathogenesis in the TgCRND8 Mouse Model
Journal of the American College of Cardiology, Vol. 74, Núm. 15, pp. 1910-1923
2017
-
Iron oxide nanoparticle-based MRI contrast agents: Characterization and in vivo use
Magnetic Characterization Techniques for Nanomaterials (Springer Berlin Heidelberg), pp. 85-120
2012
-
Apparent diffusion coefficient of hyperpolarized 3He with minimal influence of the residual gas in small animals
NMR in Biomedicine, Vol. 25, Núm. 9, pp. 1026-1032